farmakoterapi gangguan tulang 1
TRANSCRIPT
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
1/69
FARMAKOTERAPI GANGG TULANG
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
2/69
KELOMPOK 1
AYU APRILIANI (78) PUTRI RARASWATI (79)
UMMI HABIBAH (80)
AYYU WIDYAZMARA(81)
ANGGIA D. AMALIAH (82) SITI NURROHMAH (83)
AI SITI RIKA . (8!)
NISA MAULANI
TIANY SABILLA
NURMALIA S.
MILA TRI $AHYA
SITI ROSITAH
ADAM RENALDI
HOTMA G. WINOKA
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
3/69
KASUS
S%&'* I+, (N-&- P) +%',/ 70 , %*
BMI 18. D/ %',45 4%%'/ -*
%'5&'&6 +/5 %* %**,5 /6%' %'&/
&/ /**/ 5*5* /+%'/5 %' &'6
5%/5 %'/ %'*. P/% %'%+, /*
%,,5 4%'*%6* *- -* /*/4.K&,6 &'&4%/ %*5 +: / /,*
%%'/ &%&4&'&/ /*/ %*/'/ / ,,5
/4%'/5 6%+/ 6, ,,5 %/5 /*&/-.
A454%*&+
-* /'5
,,5 N-&-%'%+,;
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
4/69
ANATOMI < ISIOLOGI TULANG
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
5/69
• T,6* 6 '/* -/' '/* /5 6/
4/' "0 = /' %6%+/- %'/'/ '/ %', 56/, 5,'* + %6,6%' 33 =.
• T,6* &'6 %'/'/ '4 -* %*%6/6/*/ %'+, ,6* (,6* /%6/*/ ,, ,6*.
•
P%-,, , ,6* %,mineral tulang -* %*< ?&?&' (P)> 4'&%5&6*%. S',5,' ,6* +*, , %+. K ?&?&' %+, ,6*/'/4 %%> %* %'%+, ,6* /'/4 5
%+&5.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
6/69
P%-,, M'/5 T,6*
P'&%/K&6*%/+'&
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
7/69
T,6* A**& G%'5 A
T,6* 6 5%6&4&(,6* , ,6?&'/ 6 M%5'5%'*5 +%4/4. ,6* +%'+%
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
8/69
Struktur Tulang
Sel-sel, matrik organik, dan mineral M%'/'/ '/ 5&6*% + %*,* &&4&6/5'/. P '/5 //6 %*%4- 5'/6&/ -
'/ 56/, ?&?. S%6%6 ,6* %&/&/> &%&+6 &%&56.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
9/69
Faktor yang berpengaruh terhadap keseimb
pembentukan dan reabsorpsi tulang adalah:
// D B%'?,*/ %/*55 ,6 56/, 6 ' %* 4%-%'4 56/, '/ 6,' 4%%'. K%5,'* C// D 4 %-%/%'6/> %?&'/ 4 ,6*.
H&'& 4'-'&/ 56/&/
P%'%' '
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
10/69
PATOISIOLOGI
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
11/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
12/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
13/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
14/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
15/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
16/69
E?%5 P%**, G6,5&5&'/5&/ 4T,6*
G6,5&5&'/5&/ %4,-/ +%'+/ %?%5 %'4 ,6* %6 ,6*. P 5*6,5&5&'/5&/ /+%'/5 ,,5 %*&+/ 5&// /?6/ /%/5 (%4%'/ ''%,&/)> 5&// %'%+, 4 %-%++5 5%'4& ,6*.
G6,5&5&'/5&/ ,* %*+ 4'&,5/ %'&/ 5%6/ (%&%'&% %
P%5/ *5 6 &/ /**/ 4 %-%++5 5%6 &&
S6,5&5&'/5&/ 4 %-%++5 4%,', +&'4/ 56/, 4 ,, -* 6%4 %-%++5 &%&4&'&/.
K%'&4& ,6* 5'% %'/,5/ 6,5&5&'/5&/ //65 5'% /,6/ '%&&%&56 %,',5 4%+%,5 -* /%// &%&+6.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
17/69
GEALA KLINIS OSTEOPOROS
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
18/69
S%+%'-> -* /,'/*/ +: 6 /, %',45 *5'% &%&4&'&/> -/, 4%*6> 6/,-%'/ ,6*> 5,,- /%' 4*56 4> ,6* +%65* 4%'*%6* *> ,/. O%&4&
,* %-%++5 ,+, %%',* +,(K,> 2002).
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
19/69
Nyeri PunggungNyeri punggung yang dirasakan bukanhanya karena saat sering mengangkatbeban berat di punggng seperti tas ataukarena nyeri sendi Tetapi bisa !ugamen!adi sebuah tanda !ika tu"angmenga"ami ke ker#p#san sehingga
reaksi tubuh akan merasakan sakit dibagian punggung Tergantug !uga padabagian tubuh mana yang tu"angnyamenga"ami ker#p#s
Berkurang tinggi b Tinggi badan yang
perubahan "ebih tinggi akatetapi !ika tinggi badan berdipertanyakan Kemungkberkurangnya tinggi badanpada sese#rang pender#ste#p#r#sis
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
20/69
Kemiringan Bahu%ahu yang a&a"nya tegak dan men!adi tidak se!a!ar karena miridisebabkan karena tu"ang yang kPenger#p#san tu"ang yang menyekemiringan bahu dapat di"ihat
mudah ketika ber'ermin atau menggunakan tas ranse"
Bungkuk
Karena tu"ang yang ker#p#s dapatme"engkung sehingga akan ter"ihatdengan p#stur tubuh yang membungkuk%ungkuknya badan dapat di"ihat denganmudah !ika kita berdiri tegak atausedang ber!a"an
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
21/69
Perut menonjolKeadaan perut yang men#n!#" !uga akandia"ami ketika penyakit #ste#p#r#sister!adi Karena di perut yang men#n!#"
disebabkan karena tu"ang be"akangmenga"ami kebengk#kan
• Ke"uhan nyeri tu"ang be"akang (ba'k pain) yang menahun yahi"ang timbu" dan akan makin nyata$ apabi"a ter!adi nyeri yahebat akibat timbu"nya *raktur k#mpresi tu"ang +ertebra yamengakibatkan berkurangnya tinggi badan dan ke"ainan bentuk
• Ge!a"a timbu"nya *raktur tu"ang pan!ang hanya sebagai aki'edera yang ringan
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
22/69
BIOKIMIA KI!IK
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
23/69
BMI
18?
70Tahun?
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
24/69
I%5 M T,+,
I%5 ,+, -* '% %',45 ?5&',,5 %'/- ?'5,' &%&4&'&/5. R//5& // - 4 &'* %* /%5 ,+, F 20 5I%5 ,+, -* /**/ +%'5/ %*,6* -* /**/ 4,6 4%*,'* ,+,%-%++5 4%*,'* ,6* (Z& % 6> 20
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
25/69
,#nt
WHO %**,5 4%*,5,' D%/ M/
T,6* (DMT) %+*/ 6 , 4%%5/*&/ &%&4&'&/.2 S%' ,, %4%,', DMT 6 4'&% %'&%&4&'&/ %/** %'/ 5%'4, ,DMT %+%'/5 ,+* %'+%'
5%5, ,6*. DMT &'6 /5 T&'% 1 DMT '% +/6 T&'% 4%6 F 1.3 DMT -* '% %',45 ?5&' , '?'5,' 4 %6,-(WHO>2003).
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
26/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
27/69
-etya&ati et a
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
28/69
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
29/69
Tes BM"
T% B&% M/%'6 D%/0- ( BMD) %',45%5/5 -* /*,5 ,,5 %*,5,'
,6*. H- %66,/ % // %/ ,6* -*'% 4 /%,5 &%&4&'&/ 4//*&. T% BMD 4 /*,5 ,,5%*,5,'
/%%5/ %/ %+%6, %%&'*%*6/ ?'5,'
%4'%%5/ %%&'* %4,-/ '%/5&%%'/
&%&4&'&/ 4 *. %%*55 /*& %&'* %%'/
&%&4&'&/
%&/&' '%4& 4/% %'4 4%*&+ -* %* /+%'/5.
T% BMD /*65 ,,5
:/ -* %*6/ 4& %&4,%
4'/ -* +%',,' "0 70 , -* %4,-'%/5&
:/ -* +%',,' 6%+/ '/ #" , :?5&' '%/5&.
P'/ -* +%',,' 6%+/ '/ 70 , :6,4,
P'/ , :/ -* +%',,' 6%+/ '/ "0?'5,' ,6*.
W/ -* %6/ /%'%5&/ %+%6, %'&*%.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
30/69
T%5/5 ,,5 %*,5,' ,6*
1. A+&'4/&%'/ P&& T,**6
D/%+, ,* S/*6% P&& A+&'4/&%'- (SPA)> %',45 %4%' -* /&4%'/5 %' &&/ ,,5 %*,5,' ,D%/&%%' %*,5,' 5,* /%'6 4 ,6* 6%* +: %%*/,* +%'4 +-5 /' * -* /%'4> %5/ +-5 +&%5/ +%' 4,6 5,* /%'6 ,6* %5/ +%' ,* %,6*. SPA %*,5,' 5%, %/ ,6*> 5&'/56> '+%5,6'. S%6 6'/ " ,> 5%+-5 SPA %6 /*/5 %* /*6% +&'4/&%%' (SA) , +&'4/&%%' '- ,**6. K%%4 SA
%* SPA> 4/ SA /5 %**,5 /&&4 /5 %*/,* *>, %**,5 ,+%' '-> ,6 '//- 5%/6> 5%5,,+%' '- /5 +%'5,'*.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
31/69
2 !b"or#tiometri $ % ray &nergi 'anda( Dual – enery Xray Absorptiometry )
B*/ ,6* %4%'/ ,6* 4,**,* 4/**,6 /5%%* +%'+*/ '/* 6,> %',5 6%5> 4%+,6, '> &'*&'* 4%',. '/*'/*%+ 4%**, SPA , SA 5'% %&/5 4 %%+, '/* 6,> - /*,5 ,,5 ,6* -* +%' / %5 5,6/.
%,*5/5 5/ ,,5 %*,5,' ,64%',5 ,4, / +*/ -* 6%+/ 6. DA/*,5 ,,5 %*,5,' &6 5,* %/%'6 ,6* 4 /6 6%* +: ,/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
32/69
3. T&&*'?/ K&4,/ K,//?P%'/4%'6
J$T P%'/4%'6 (PJ$T) %6 /5%+*5%*,5,' ,6* '+%5,6' 6%* +: 5&'/56 %' '+%5,6'. D&/ '// 4%* '- '%*,6' 4 6%*. W6,4,'// 6%+/ '% '/ J$T -* /*,5
%*,5,' BMD ,6* 4,**,*> , %6%+/ /**/ '/4 %5/5 4%*,5,' ,6. U,5 //> %5/5 %'%+, 4 /*,,5 %%,5 '%/5& 4 ,6* &%&4 ,6* 4%'/4%'6.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
33/69
!. P%*,5,' U6'&, 4 ,6
D/*,5 ,,5 %/*& +%'+*/ 5%',D6 %/*& &%&4&'&/> A6 J,/U6'&, (JUS) %*,5,' 5%%4 *%6&,' -* +%'*%'5 %4* ,6*. /5 %+6> *%6&+* ,' 5 +%'*%'5 6+.
/5 ,6* 5&'/56 6,' /4/ ,6* '+%/%'/&' /4/> *%6&+* ,' 5 +%'*%'5 D%* %/5/> :5, '/ '/ *%6&,' 4 /5/5 %* ,6 ,6*',5,' '+%5,6' 4 +*/ 6 ,6*.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
34/69
Alkaline Phosphatase
A656/% 4&40% /*,5 %+*/ 4% '4%-5/ ,6* 5'% %/ / /4'&,5/ &6%
&0%&+60 . P &%&4&'&/ 5/C/ 656/% 4&46 ,6* +/- %/*5. P :6 %&40,'&C%' ,6* %/*5 5/' 5/' , 56/ 6/4 %/*5 %6 +%+%'4 ,> 5%,/ ,6/ %(L%> 2001).
Pemerika"aan *abotorium (Pemerik"aanPenanda%Penanda Biokimia Turnovr Tulang
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
35/69
#enguraian Kolagen
K&6*% 6 4'&%/ , 6 ,6* 5,6/. K%/5 5&6*% /
-'&@-4'&6/% > 4'&%/ , ,+, 5%6,'. /5 0,'&C%' ,6* %/5/ %* -'&@-4'&6/% -* 5%6,'. T/*5 -'&@-4'&6/% /56/4 , 6%+/ %%6 %&4,%.
B%+%'4 % 6+&'&'/, %6 5%+*5 ,,5 %*,5,' +*4'&%/ 5&6*% 6 ,6* 6 -* /%+, 8&66*% 8'& 6/55&6*% 6 ,6* /,'/5 &6% %6 &0%&+60 -* %-%'4 ,6*8'&76/5 /6%45 '/ ,6* ,,' -* /5%6,'5 /5 +%',+'%+&'+/ ,6* /5> /*5 5&6*% 8'&76/5 -* /5%6,'5 %5/ +%'+ (L%> 2001).
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
36/69
Osteo$al$in
O0%&868/ 6 ,6* -* /+, &6% &0%&W6,4, +,5 %',45 +*/ '/ '/* /, %,,' // /6%45 5% 6 6/' ' 5'%4 /*,5 ,,5 %*,5,' ?&'/ ,6* (L%> 2
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
37/69
T%'4/ S/%/
!
Inhala"ikorteko"teroid
do"i" tinggi
Kal"inotin
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
38/69
Penurunan
do"i"
korteko"teroid
oral "e+ara
bertaha#
Makanan yang
mengandung
kal"ium dan
,itamin -
Para"etam
ol
Makanan yang
mengandung
kal"ium dan
,itamin -
.ji Biokimia
Klinik Penyakit
/"teo#oro"i"
!"mado"i" tinggikortiko"teroid
oral
/"teo#oro"
i"
Kal"inotin
Bi"o"onat
alok"ien
Tera#i 3i"ik
!*'/ITM!P&N4!KIT
A"g#ritma Terapi
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
39/69
A"g#ritma Terapi
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
40/69
T%'4/ '5&6&*/
1. K6/,
K6/, ', /+%'/5 6 ,6 -* ,5,4 ,,5 %%* /4%'/'&%5,%' 4%',5 ,6*.
S%/ &'6
K6/, G6,&% (T+6%) #00 *
K6/, 65 (T+6%) 300 *
S%/ P'%6
K6/, G6,&% (I%5/) 10=
2. // D M%+&6/
S,46%% C// D %6 %,,55 %/*55 BMD> +/ %*,'*/ ?'
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
41/69
3. B/?&?&
I/+// '%&'4/ ,6* &'6 +&'6
A6%'&% (&@) ///5/5 ,,5 4%%* (" *4%': (10 *'/) &%&4&'&/ 4 :/ 4&%&4,%
R/%'&% (A&%6 " *'/) ///5/5 ,,5 4%':4%%* &%&4&'&/ 4 :/ 4&%&4,% %' 4'/ -* %%'/ *6,5&5&'/5&/ /%/5 (4'%/&% %' 7>" *
6%+/ +%') ,,5 4%-5/ 5'&/5.
T%'4/ '5&6&*/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
42/69
!. S%6%/C% E'&*% M&,6&' (SERM)
R6&?%@/% %',45 *&/ %%'&**% 4 '/* ,6*%',45 *&/ 4 4-,' ,%',. BMD 4/**,6 %/*5 %+%' 23 = %,',5 ?'5,' C%'%+'6 4/+,5/5 %,',5 ?'5,' +%65*.
R6&?%@/% (EC/) #0 * '%%'4&' %%'&*% %6%5/? -* %'%&'4/ ,6* %,',5 4%%+%,5 ,6*.
T%'4/ '5&6&*/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
43/69
". K6/&/
B%' %* &'& 4'/'&/> 56/&/ +%'4%' %*,'
%&%/ $ 5%6%' /'&/ 5%/5 %'/ 4%/*5 556/, %',.
S%/
$6-' (/' /%5/) 100 UI6> 200 UI6
M/6/ (/' /%5/) "0 UI6> 100 UI6
T%'4/ '5&6&*/
T / 5 6 /
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
44/69
#. E%'&*% %'4/ &'&6
E'&*% %,',5 5/C/ &%&56 >%*//+// 4'-'&/ (PTH)> %/*55 5&%'/ 6/'/&6 +&'+/ 56/, /%%,',5 %55'%/ 56/, */6.
E?%5 4%/*5 BMD '/ %'4/ %%'&*% %'4/5&+// %6%+/ 5%/6 '/4 %?%5 -* //65 &6% +/&?&?& , %'/44/ 6%+/ +%' '/4 '6&@/?%%.
S%/
E%'& +6% (%%'&*% 3 *> 0>#2" *> 1>2"0 *)
K6/&*% +6% (E'/&6 2 *> &'%,%'& % 1 * )
T%'4/ '5&6&*/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
45/69
7. /&%%'&*%
I&?6C& 4 %,',5 4% '%&'4/ ,6* %/*55 %/ ,6*
8. T%&%'& S%'&/ A+&6/5
A'&*% 4 /*,5 %+*/ %'4/ 4%**/4&*&/% 5/+ 4%-5/ /4&?// ,4, %/.
S%/ '/&6 54,6 6,5 !0 *
T%'4/ '5&6&*/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
46/69
T%'4/ P%+%,5 T,6*
1. H&'& 4'/'&/ :
M%*,* 3! /& 4%' 6 PTH ,/.
D&/ %'4/ ,,5 4%'/&% /*5 4 %4%'+/5/ B%*,'*/ '%/5& ?'5,'. (D&/ 20 * ,+5,)
2. 6,&'/
6,&'/ %/*55 5/C/ &%+6 4%+%,5 ,6
T i % k l i
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
47/69
Terapi non %armakologi
D/% B%'%/ %'&5&5
L/ ?//5
B%'// *' /5 ,
M%**,5 4%6/,* 4/**,6
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
48/69
T%'4/ H%'+6
1 R $6
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
49/69
1. R% $6&C%'D%5'/4/ T%**/ %' 6 ', +/ -*+/ ,+, 6/' / 4* ',4, /
%6,', E'&4 A/> %6/,'6// ,+, / A%'/5 U'.B,*+,* %' / 5/' +%'+*+* +/- 5%'/* ,,5 /*,5%'4/.
T% /6/ &%' %6 %,,55 +: %**/ %' %*,*/&?6C&> + 5// +/ -* %*/65 %?%5 %4%'/ %'&*%6 ,+,. I&?6C& %6 %,,55 4&%/ 6 4%*&++%+%'4 5&// -* %'5/ %* %&4,%> 5%% ,*> &%&4&'&/. N,> 4' 4%%6// %6 %-'/ %?%5 4/* '/%*5&,/ %'&*%> ,* +%+%'4 5%5:/' %*5% /&?6C&.
P O+ I /5 /
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
50/69
P%**, O+ I/5/
S%**/ %' 6 ,+%' '/ +-5 ,'// %',5 56/,> 5*%/,> //> ?&?&'> 56/, //. %**/ %' 6 ,+
5- /&?6C& (+ 5// -* +%'/5 %4%'/ %'&*% /%,5+-5 ).
P%*&+ O%&4&'&/> K%% ,* > M%&4,% K5%'
O%&4&'&/
K'% 5' %'&*% %,', %6 %&4,%> '//5& :/%*%+*5 &%&4&'&/ (5%'&4& ,6* -* /*/?/5) /5. B,/ %,,55 +: %5'5 %556,/? '/ /&?6C& %**/ %'%4%'6+ 5%/6* ,+/ ,6* +5 %/*55 5%/%'6 ,6* 4 :/ 4' 4%'/%&4,%. T%4/ +,5/+,5/ 4%%6// 6%+/ 6, /4%'6,5.
S% / %' %'%/ 6
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
51/69
S%**/ %' %'%/ 6+%'+*/ %/ > %',5 %/,'%> +6%> 54,6> %5'/'> %5'5 ' ,// /&?6C& %'%,. H6 // ,4 /4%'/45 %+*/ ,,5 &4/56 (5,6/) 46/5K'% 5,'*- ,/ *4*> 4%*&+ /'/ /%6%+// 3 4/ # +,6 4%*: %&'* 4'&?%/&4%': 5%%.
1#sis dan Adminitrasi
1#sis untuk de&asa
• H%'+6 5%'/* (/*,5 ,,5 %) 1 4/ 2 +,* 5%'/*, +%'+,* 4,5 %6/ 8 &. /' 4 ,,5 12 /, 2 4/ 3 *5/' 4%' '/
• ', +,+,5 (%'%/ 6 54,6) !01#0 * 4%' '/> , 288" * /&?6C& %**/ %'
• T/*,' (1 "> 30= 65&&6) #0 4/ 100 %% (3 4/ " L)> 356/ 4%' '/ ,*5/ %+ /' 4 %+*/ %
• E5'5 /' (1 1) 1 L> 3 56/ 4%' '/ ,*5/ %+ /'
4 %+*/ %
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
52/69
2. S&-
• AS && D',* A//'/&(DA) %-%,,/ +: 2" *'
4%' '/ '/ 4'&%/ 5%%6/ 4%*,'*/ '//5& 4%-5/ ,*.M? 5%% '/ 4'&,55%%6/ ,*5/ 5'% /*5/**/ 6%5 5 %, *> %'>/%'6> C//> 5,*6%5 %, -* '%.
• D%* 5,* &- %+*/?/&%'&*%> 5 ,46/ %'&*%4 :/ 4 %'4%,/>%/** 4 %&4,% 5'56/, 6 ,6* /5 5%'5/5/ +-5. M5 &%&4&'&/4 //'/.
D&/M%&4&,% -4&120*
MEKANISME KERA
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
53/69
MEKANISME KERA
P'/6 %'&*% '%%4&'*&/ /%'&*%/%??% / 4'%%&4,6:&%> +, :%5%'&*%/ %??% /4&%&4,6 :&%
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
54/69
G%6 %&4,%
M%*/* /6 ,/ 56// -* 46/*> +-5 6/ %-/4,65 +:
&& ,*5/ %/ 6%'/? -* %?%5/? ,,5 :/ -4 , /5 5 %*+/6 %'4/ 4%**/ &'& (HRT)%&4,%. S%+, 2010 U6 &6% 4' 4%%6// %%,5 +:&& %'%/ 4%*,'* 2#= 4 & ?6% +%'5%'/* / (,* /5%6 %+*/ *%6 C&&&').
&%&4&'&/
4%%6// 6+&'&'/, %6 %%,5 +: %'&*% +/ (
4-&%'&*%) / && / 4 %*+ 5%'&4& ,6*> %'6/ %* &%&4&'&/. P%%6// 6%+/ 6, /4%'6,5.
3 Bl k h h
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
55/69
D%5'/4/ T
B65 && 6> +%'+,* /**/
/%,5 / , / %' /,' A%'/5U'. S%&'* **& 5%6,'* +,%',4> +65&& ,* /5%6 %+*/ B65 5%'&&>+,*+%> +,*:&'> ,:'&&. M%',45'/4* 5' (5%, +*/ +: '/) -* /*,5 ,,5 ,, 4%*&+.
K,* K//H/ && %*,* *6/5&/ (%-: *,6)> /&?%',6/ (%* %?%5 //?6/)> > ,*5/> 4-&%'&*% (%'&*%+/)> / ' +%+%'4 5/? 6/-.
3. Bla$k $ohosh
D&/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
56/69
• D%:D&/ -* /,'5 '/ +65 && +%'5/' ' 204/ 80 * 4%' '/.• U,5 +65 && /,'%> -* %* 2 4/ !
6> 1 4/ 3 56/ 4%' '/ 6 /' , %. D, 54,6, +6% +/- %+%'/5 &/ '/ -*/'%5&%/5.
E?%5 S4/*B%+%'4 &'* -* %*+/6 &/ /**/ %/6/5%',5 5/ 4%',> %5 4> /'%> 4,/*-%'/ %/> ,6> %-, ,* -* 6+> '%&C/,6> ,> +%' +. A /5 ',+65 && /5 A %/6/5/ 5&// &'&%55%' 4-,'> %&%'/&/> 55%' &C'/,> , ,&' ?/+'&/.
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
57/69
MONITORING
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
58/69
1. M&/&'/* BMD (+&% %/0- )2. A656/% 4&40% (ALP)
3. P'&8&66*% 0-4% 1 /&70%'/6 4'&4%40/% (P1NP)
!. $'&L4
". N7/ O0%&868/
#. M&/&'/* %* P%%'/5 R/&6&*/
7. M&/&'/* BMI , IMT
(
1 M&/&'/* BMD (+&% %/0
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
59/69
1. M&/&'/* BMD (+&% %/0
T,, BMD , 6// 4%' ,6* 6 ,,5 %, %'%4& 4%*&+> /*&/ 4%%'/ %* '//5& &%&4&'&/> %'/4%-%++ +%'5,'*- ,6* %' %4> %/6/ 4%*&+ -* %,/> %, 4/%%* 4%*&+ 5&'/5&%'&/.
S4%6 %', , ,'/
5'/%'/ &%&4&'&/ +%''5 B&% M/%'6 D%/- (BMD) %* T
-* %/6/ 5% 5%4 ,6* &'* %: , -/, %+*+%'/5, N&'6 4+/6 1 SD '/ T&'%O%&4%/ 4+/6 1 SD 4/ 2>" SD '/ T&'%O%&4&'&/ 4+/6 2>" SD '/ T&'% , 5,'*
2 A656/% 4&40% (ALP)
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
60/69
2. A656/% 4&40% (ALP)
ALP / ,6* 5'- /**/ 6 %', %/** +-5 /45
,,5 %/6/ 4'&% %+&6/% ,6* 5,,- %/6/ %5/C/ &%&+6 ,,5 %/6/ 5%6/ 4 %4&+/6/%'.
S4%6 ' , ,'/
N/6/ &'6
4'/ 90239 L
:/ F !" , 7#19# L
:/ Q!" , 872"0 L
3. P'&8&66*% 0-4% 1 /&70%'/6
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
61/69
3. P'&8&66*% 0-4% 1 /& 0%'/64'&4%40/% (P1NP)
P%' ,6
%',45 4%/?/5 6,,5 %/6/ 4%,6*.
P/% -* /&+4%*&+ %/*5 5'
S4%6 '
N/6/ &'6 P1NP "*L , *6.
! $'&L4
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
62/69
!. $'&L4
S%//C/ %4/ Q70= 4%/?// 80=. K' $'&L4 /4%*',/ ,/> %/ 5%6/ /56, /
4,5 %* 6 5' %'% &'% '/.
P%%'/5 $'&L4 4 /45/ %+*/ 6 4%, 4 4%*&+ %* /'%&'4/? %4%'/ +/4&4&%/**, %',- %'/ 4%,', 5' $'&L4 6 %/** 4 /4'%/5/ /6 4%*&+.
P%%'/5 5' $'&L4 6%+/ %//? 6 %%+&6/% ,6* /+/*5 %* 4%%'/5 BMD.
S4%6 %',> 46 , ,'/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
63/69
N/6/ &'6- 4'/ ,/ 30"0 , 0>01# 0>"8! *6.
U/ "070 , 0>10! 0>70! *6
,/ Q70 , 0>10! 0>8"! *6.
W/ 4'%%&4,% 0>02" 0>"73 *6
P %&4,% 0>10! 1>008 *6
" N7/ O0%&868/
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
64/69
". N / O0%&868/ O0%&868/ %',45 4'&0%/ &5&6*% -* %'4 46/* +-
/4'&,5/ %6 &%&+6.
P%%'/5 &0%&868/ %',45 4'%%' -* +/5 ,,5***, %+&6/% ,6* 4 4%+%,5 ,6* 4%*(+&% 0,' &C%').
P%%'/5 &%&6/ %'/* /45/ %+*/ +/&'5%' :6 4&+ 4%+%,5 ,6* ,,5 %/6/ %?%5/C/ /6 4%*&+.
H/6 4%%'/5 &0%&868/ 8,5,4 5,'0 +/6 6
4%+%,5 ,6* M%&% 4%%'/5 &0%&868/ 6 %K-%76/5% /,&
(ELISA).
N/6/ &'6- 6 10>1 9>! * 6.
#. M&/&'/* %* P%%'/5 R/&6&
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
65/69
#. M&/&'/* %* P%%'/5 R/&6&
G+' '/&6&*/5 -* 5 4 &%&4&'&/ 6 - 4%/4/
%' '+%5,6' -* 6%+/ 6,%. P 4%%'/5 '/&6&*/5 ,6
* +/5 ,,5 %%,5 - ?'5,'. G'/* &%&4&'&/
G'% 0 /5 '%,5/ (NORMAL)
G'% 1 ?'5,' //6
(+%'5,'*- /**/ C%'%+' 20= 2"=)
G'% 2 ?'5,' &%'%
(+%'5,'*- /**/ C%'%+' 2"= !0=)
G'% 3 ?'5,' %+
(+%'5,'*- /**/ C%'%+' 6%+/ '/ !0=)
(WHO> 200!).
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
66/69
7. M&/&'/* BMI , IMT
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
67/69
7. M& &' * BMI , IM
IMT //,* %* %**,5 +%' + 6 5/6&*' (5*) /++ 6 %%' 4*5 , (2).
IMT B%' B (5*) T/**/ B (2)
P%+*/ IMT %,', WHO ,,5 ' A/
F 18>" U%':%/*
18>" 22>9 N&'6
Q 23 2!>9 OC%':%/*
2" 29>9 O+%/ I
Q 30 O+%/ II (WHO> 200!).
-umber2
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
68/69
Guyt#n A,$ 3a"" 4E$ 0556 %uku A!ar Fisi#"#gi Ked#kteran$ Edisi I7 Penerbit%uku K
Pear'e$ E .//8 Anat#mi dan Fisi#"#gi untuk Paramedis 4akarta2 Gramedia
Kasdu$ 1 .//. Kiat -ehat dan %ahagia di Usia Men#pause 4akarta 2 Puspa -&ara
Adi Priyatna Peran Pertanda Tu"ang 1a"am -erum Pada Tata"aksana Oste#p#r#sisK"inik FKUI 9#" .8 n#: .//6
;3O -'ienti
-
8/17/2019 Farmakoterapi Gangguan Tulang 1
69/69
Lane$ NE .//0 'steoporosis )apuh Tulang % Petun*uk untdan +angkah,langkah Pengaman untuk -eluarga 4akarta 2 Persada